Brexit – cliff edge or catapult?
With the end of the transition period in sight, will Brexit bring a fanfare or a frenzy to Pharma?
FACILITATED BY
CLAIRE THOMPSON | Chief Executive Officer | Agility Life Sciences
PANELLISTS INCLUDE
SCOTT JOHNSTONE | Chief Executive Officer | Scottish Lifesciences Association
HUGO FRY | Managing Director & Vice President | Sanofi UK & ABPI
TAMSIN BERRY | Director | PHP
JON NEAL | Managing Director | Takeda UK & Ireland
TASMINA GORAYA | Partner, IP and Life Sciences Regulatory | Taylor Wessing